-
Excellent Team
3 senior R&D doctors
5 senior foreign consultants
More than 80 high-paying technical
R&D teams -
Multiple Platforms
Human,animal,pet
ELISA/GICT/IFA/CLIA platform
70+ Human rapid test kits
30+ Veterinary test kits -
Production Ability
5000 square meters area
Professionally equipped base
100,000 level purification base
High-efficiency production lines -
Quality Assurance
CE certified
ISO13485 quality system certification
SOP standardized
production/management
BOTAl was established in 2018, with its headquarters in Ningbo City, China, and is a high-tech enterprise with immunodiagnostic technology as the core and- integrating R&D, production and sales.
Relying on the biological raw material technology platform independently developed and produced by antigen and antibody, as well as mature ELISA platform,GICT platform,IFA platform and CLIA platform,BOTAI has developed and formed POCT reagents in seven major fields covering infectious disease detection, vector-borned disease detection, respiratory disease detection inflammation detection, tumor detection, zoonotic disease detectionand animal(pet/economic animal) disease screening, and has now formed the depth of the industrial chain from upstream core raw materials to diagnostic reagents.Serving more than 150 countries and regions around the world.
